TOP

Awards

Awards



Sino Biopharmaceutical Limited Awards & Rankings


The Company was named "Fabulous 50" in 2017 by Forbes Asia second year in a row, one of five pharmaceutical companies to be honoured the title.

Sino Biopharmaceutical Ltd. was named one of “China's Top 500 Companies” by Fortune China in 2015, 2016 and 2017, ranking #447, #410 and #442 respectively.

The Company also ranks within the top 10 in the pharmaceutical industry by revenue, and ranks at number 4 in terms of profits in 2016.

The Company debut on Forbes Asia's Fabulous 50 List in 2016 (Fab 50), among big names such as Alibaba and Baidu, and one of only three public companies from Hong Kong that made the list.

The Company was selected as a constituent of Hang Seng Composite Industry Index – Consumer Goods and Hang Seng Composite Small Cap Index both with effect from 8 March, 2010.

The Company was awarded “Chinese Outstanding Enterprise Achievement Prize” by the Capital Magazine in May, 2006.

The Company was awarded “Best under a 1 US Billion within the Asia Pacific region in 2005” by Forbes Asia.

The Company was awarded “Hong Kong Outstanding Enterprises 2005” by Economic Digest.

The Company was awarded “Red Herring Small Cap 100” by Red Herring Magazine in 2005.


Other Corporate Awards


CT Tianqing was designated “2014 Best Industrial Enterprise in the R&D of the Pharmaceutical Product Line in the PRC” by the PRC's Pharmaceutical Industrial Information Centre.

CT Tianqing was designated “State Recognized Enterprise Technological Centre” by State Development Reform Committee, Ministry of Science, Ministry of Finance, Customs Head Office and State Tax Bureau.

CT Tianqing was placed 25th of “2013 Top 100 Pharmaceutical Industrial Enterprises in the PRC” by the Bureau of Medical Statistics of the PRC.

CT Tianqing was awarded “2012 Science and Technology Honor Award in Jiangsu Province” by the Government of People of Jiangsu Province.

NJCTT was designated “Engineering Technological Research Centre for treating tumors and cardiocerebral phytochemistry injections of Jiangsu Province” by the Science and Technology Committee of Jiangsu Province and Bureau of Finance of Jiangsu Province.

NJCTT was awarded “2014 China Chemical Pharmaceutical Industry Top 100 Industrial Enterprises in respect of comprehensive strength” in Chempharm Annual Summit 2014.

Jiangsu Fenghai was designated “Engineering Technology Centre of Parenteral Nutritious Medicines in Jiangsu Province” by Bureau of Science and Technology of Jiangsu Province and Bureau of Finance of Jiangsu Province.

Jiangsu Qingjiang was designated “Recognized Enterprise Technology Centre in Jiangsu Province” by the Economic and Information Committee of Jiangsu Province, the Development and Reform Committee of Jiangsu Province, Bureau of Science and Technology of Jiangsu Province, Bureau of Finance of Jiangsu Province, State Tax Bureau of Jiangsu Province, Local Tax Bureau of Jiangsu Province and the PRC's Customs of Nanjing.

Qingdao Haier was designated “Qingdao Chemical and Pharmaceutical Engineering Research Centre” by Bureau of Science and Technology of Qingdao City, Beijing Tide and CTGP were designated “High and New Technology Enterprise” by Beijing Municipal Science and Technology Committee.

Beijing Tide was designated “Pharmaceutical Industry Enterprise (non-listed) with most investment value in the PRC” by the PRC's Pharmaceutical Industry Information Centre.

Beijing Tide was awarded “Drug Delivery System Preparation Technology and R&D Centre of Beijing City” by the Science and Technology Committee of Beijing City.

Beijing Tide was awarded “The Potential Enterprises in the PRC in 2009” by Forbes Asia.



Product Awards


“Tianqingganmei and its production method” received the “The Tenth Chinese Patent Gold medal” jointly granted by World Intellectual Property Organization and State Intellectual Property Office of the PRC.

“Tianqingganmei injections” won the gold medal in “The Third Chinese International Patented and Famous Brands Exhibition” organized by State Intellectual Property Office of the PRC.

“Ganlixin injections and capsules” was commended “People's Safe Medicine Branding” in “Safe Medicine for Everyone”, an event jointly organized by Health Times magazine, Health Digest magazine, China Health magazine and People's Health magazine.

“Tianqingganmei injections” received “Scientific and Technological Progress Second Honor Award” from Jiangsu Provincial Government.

“Tianqingganping enteric capsules” was awarded “National Torch Programme Project Certificate” from the PRC's Ministry of Science and Technology.

“Kaishi injections” received “National New Key Product Certificate” jointly awarded from the PRC's Ministry of Science and Technology, the PRC's Ministry of Commerce, the PRC's National General Administration of Quality Supervision, Inspection and Quarantine and the State Environmental Protection Administration of the PRC.

“Kaishi injections” received “Beijing Science and Technology Second Honor Award” from the Beijing Municipal People's Government.

“Entecavir”, “Biapenem”, “Getai”, “Renyi”, “Tianqingning” and “Yitong” were granted “High and New Technology Product Confirmation Certificate” by the Bureau of Technology of Jiangsu Province.

“Kaifen injections” received “National New Key Product Certificate” jointly awarded from the PRC's Ministry of Science and Technology, the PRC's Ministry of Commerce, the PRC's National General Administration of Quality Supervision, Inspection and Quarantine and the State Environmental Protection Administration of the PRC.

“Biapenem Raw Material and Powder” received “State Torch Programme Project Certificate” from Torch High and New Technology Industry Development Centre of Ministry of Science and Technology.

“Entecavir Raw Material and Powder” received “State Focus New Product Certificate” from PRC's Ministry of Science and Technology, PRC's Ministry of Environmental Protection, PRC's Ministry of Commerce and State Quality Control and Inspection Bureau.